South Korean memory giant reported 37.6 trillion won in operating profit on 52.6 trillion won in revenue, a 405% year-over-year jump and the highest operating margin in its history at 72%, as HBM and high-density server DRAM rode an AI-driven demand wave.
Regeneron's one-time intracochlear gene therapy for OTOF-related deafness cleared the FDA 61 days after BLA filing, the first gene therapy product approved under the Commissioner's National Priority Voucher pilot program.
Devin's maker is in talks to raise hundreds of millions at $25 billion just seven months after a $10.2 billion round, putting fresh pressure on a sector already reshaped by the SpaceX-Cursor option and Anthropic-OpenAI competition.
China Huaneng Group fully energized the 504 MW Shandong Peninsula North L offshore wind farm on April 7, 2026, installing 42 twelve-megawatt turbines on jacket foundations in 52 to 56 meters of water — the deepest fixed-bottom offshore wind project ever built in China.
UnitedHealth CEO Stephen Hemsley told investors the insurer will spend roughly $1.5 billion on AI in 2026, with a target of 2:1 returns, even as the STAT+ investigation puts the total bet at $3 billion and questions what the shift means for patients.
Canonical releases Ubuntu 26.04 LTS on April 23, shipping Rust-based coreutils and sudo as defaults, GNOME 50 without X11, and a 6 GB RAM floor that redefines the distribution's baseline for the next decade.
OpenAI unveiled workspace agents on April 22 — shared, always-on Codex-powered agents that operate inside ChatGPT Business, Enterprise, Edu, and Teachers plans, with native integrations for Slack, Salesforce, Google Drive, and SharePoint.
Alibaba's new flagship tops SWE-bench Pro, Terminal-Bench 2.0 and four other coding leaderboards, but ships as a proprietary hosted model rather than an open-weight release.
Tokyo Electric Power Company restarted commercial operations at the world's largest nuclear plant on April 16, 2026, ending a 14-year shutdown of TEPCO's entire nuclear fleet since the 2011 Fukushima Daiichi accident.
Four months before the EU AI Act's core provisions take effect, the European Commission's public register shows that only eight of 27 member states have designated the national authorities required to enforce it.
A single infusion of Johnson & Johnson's Carvykti rendered all 20 patients in a Dana-Farber phase 2 trial undetectable for residual disease, the first time CAR-T therapy has been tested in a precursor cancer setting.
Anthropic's first major Bun release since acquiring the runtime tackles long-running-process leaks, adds isolate, parallel and shard test flags, and lands days after Pulumi made Bun a fully supported infrastructure-as-code runtime.